What is Esperion Therapeutics's PP&E (net)?

Esperion Therapeutics (ESPR) reported PP&E (net) of $311K in Q1 2026.

How has Esperion Therapeutics's PP&E (net) changed year-over-year?

Esperion Therapeutics's PP&E (net) increased by 36.4% year-over-year, from $228K to $311K.

What is the long-term trend for Esperion Therapeutics's PP&E (net)?

Over 5 years (2020 to 2025), Esperion Therapeutics's PP&E (net) has grown at a -23.3% compound annual growth rate (CAGR), from $1.28M to $338K.

What does PP&E (net) mean?

Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.

Esperion Therapeutics ESPR PP&E (Net)

PP&E (Net) at other companies

AmgenAMGN

$8.22B+23.0%

NewAmsterdam Pharma CompanyNAMS

$379K+59.2%

Lexicon PharmaceuticalsLXRX

$1.75M-24.0%

Zevra Therapeutics, Inc.ZVRA

$430K+1.9%

Eton Pharmaceuticals, Inc.ETON

$372K+1,591%

Nurix Therapeutics, Inc.NRIX

$21.7M+17.6%

Other financials

Income statement

See full

Revenue$80.1M+23.2%

Operating income-$6.6M+70.2%

Net income-$25.2M+37.7%

EPS (diluted)-$0.10+52.4%

Balance sheet

See full

Cash & equivalents$156.2M+36.2%

Total debt$155.2M+6.1%

Total equity-$307.9M+27.8%

Total assets$462.5M+42.7%

Cash flow

See full

Operating cash flow-$27.7M-22.5%

CapEx$189.0K—

Free cash flow-$27.9M-23.3%

Valuation

See full

Market cap$811.73M+283%

Enterprise value$810.81M+233%

P/S1.9×+1.1×

Profitability

See full

Operating margin18.1%+12.7pp

Net margin-34.8%+8.0pp

FCF margin-30.7%—

Returns & leverage

See full

Return on equity-260.8%—

Debt / equity0.8×—

Current ratio1.5×+0.4×

Where this comes from

Reported directly by Esperion Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: Esperion Therapeutics’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Esperion Therapeutics's pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Esperion Therapeutics's PP&E (net)?: Esperion Therapeutics (ESPR) reported PP&E (net) of $311K in Q1 2026.
How has Esperion Therapeutics's PP&E (net) changed year-over-year?: Esperion Therapeutics's PP&E (net) increased by 36.4% year-over-year, from $228K to $311K.
What is the long-term trend for Esperion Therapeutics's PP&E (net)?: Over 5 years (2020 to 2025), Esperion Therapeutics's PP&E (net) has grown at a -23.3% compound annual growth rate (CAGR), from $1.28M to $338K.
What does PP&E (net) mean?: Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.